Menu

Alan Hambelton

Partner

I love working with innovative companies that are defining the future of technology and medicine.

ahambelton@cooley.com

Alan D. Hambelton heads Cooley’s Seattle corporate practice. Alan represents public and private companies in a wide range of matters, including corporate securities, public offerings, private financings, mergers and acquisitions, corporate governance and general counseling.

Download full bio 

Experience

  • Cytokinetics – $450 Million Convertible Senior Notes Offering 

  • Dutch Bros – $556.8 Million IPO 

  • Eliem Therapeutics – $92 Million IPO 

  • Instructure Holdings – $250 Million IPO 

  • Accolade – $288 Million Convertible Notes Offering 

  • View all

Education

  • University of Virginia School of Law
    JD, 2007

  • University of Washington
    BA, International Studies
    2003


Admissions & Credentials

Washington

Memberships

  • Washington State Bar Association